Mizoribine

Generic Name
Mizoribine
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C9H13N3O6
CAS Number
50924-49-7
Unique Ingredient Identifier
4JR41A10VP
Background

Mizoribine has been investigated for the treatment of Rheumatoid Arthritis.

Indication

预防器官移植时排斥反应。

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

Comparative Efficacy of Mizoribine With Mycophenolate Mofetil for Living Related Kidney Transplantation Recipients

First Posted Date
2023-11-02
Last Posted Date
2023-11-02
Lead Sponsor
Lee's Pharmaceutical Limited
Target Recruit Count
152
Registration Number
NCT06114953
Locations
🇨🇳

Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

🇨🇳

First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

🇨🇳

The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China

and more 3 locations

An Open Study on the Preventive Effect of Early Mizoribine Conversion on BKV Nephropathy in Renal Transplant Recipients

First Posted Date
2022-03-24
Last Posted Date
2022-03-24
Lead Sponsor
Lee's Pharmaceutical Limited
Target Recruit Count
30
Registration Number
NCT05293704
Locations
🇨🇳

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)

First Posted Date
2015-02-26
Last Posted Date
2018-01-30
Lead Sponsor
Sanofi
Target Recruit Count
91
Registration Number
NCT02373202
Locations
🇯🇵

Investigational Site Number 392039, Fukuoka-Shi, Japan

🇯🇵

Investigational Site Number 392006, Sasebo-Shi, Japan

🇯🇵

Investigational Site Number 392023, Takaoka-Shi, Japan

and more 37 locations
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy